Analysis of factors associated with the indication of anticoagulant therapy in chronic atrial fibrillation. Prospective study of 170 patients admitted to an Internal Medicine Department

Citation
Vf. Ferrer et al., Analysis of factors associated with the indication of anticoagulant therapy in chronic atrial fibrillation. Prospective study of 170 patients admitted to an Internal Medicine Department, REV CLIN ES, 200(4), 2000, pp. 203-207
Citations number
38
Categorie Soggetti
General & Internal Medicine
Journal title
REVISTA CLINICA ESPANOLA
ISSN journal
00142565 → ACNP
Volume
200
Issue
4
Year of publication
2000
Pages
203 - 207
Database
ISI
SICI code
0014-2565(200004)200:4<203:AOFAWT>2.0.ZU;2-E
Abstract
Background. Anticoagulant therapy reduces the risk of stroke among patients with chronic atrial fibrillation. The objective of this study was to evalu ate the use of anticoagulant therapy and to analyze the factors associated with the indication of anticoagulants in patients with chronic atrial fibri llation. Patients and methods. Prospective study of all patients with chronic atrial fibrillation admitted to our Department of Internal Medicine from February 1997 to September 1998. From each patient data related to the cause of atr ial fibrillation, other associated vascular risk factors, use of anticoagul ant and/or antiplatelet agents and contraindication to anticoagulants were recorded. Results. A total of 170 patients with chronic atrial fibrillation were stud ied. The mean age of patients was 77 years (range: 49-94). One hundred and four patients (61%) were older than 75 years. Atrial fibrillation was the m ain cause for admission only in 11 patients (6.5%). One hundred and sixty-s even patients (98%) had indication for receiving anticoagulant therapy; how ever, it was indicated in only 67 patients (39%). In other 68 patients (40% ), antiplatelet agents were used. Patients over 75 years received anticoagu lants less frequently (p<0.0001). Factors associated with the prescription of anticoagulants in the bivariate analysis included: diabetes mellitus (p = 0.046), high cholesterol level (p = 0.023), age less than or equal to 75 years old (p < 0.0001), history of previous embolic events (p = 0.001) and valvular atrial fibrillation (p < 0.0001). The multivariate analysis showed that only two factors were indeed associated with the prescription of anti coagulants: age I 75 years (OR: 6.15) and valvular atrial fibrillation (OR: 4.24). Conclusions. Anticoagulant therapy is underused in patients with chronic at rial fibrillation, particularly in elderly patients.